Literature DB >> 17546910

[Demographic factors influencing hepatitis B and C infection in Benghazi, Libyan Arab Jamahiriya].

Huda Kutrani1, Abdulsalam El-Gatit, Amina Shekhteryea, Yousef El-Gitait, Omar Sudani, Saad Akoub.   

Abstract

We studied the epidemiology of hepatitis B and C infection among a sample of patients referred to the Department of the Infectious and Endemic Diseases at Al Jamahiriya Hospital in Benghazi. Of a total 3250 patients, 40% were randomly selected. Of these, 51.2% were infected with hepatitis B virus, 46.9% with hepatitis C virus and 1.9% with hepatitis B and C. Younger patients and single patients were more prone to hepatitis B infection, while older patients, married patients and travellers were more prone to hepatitis C. About 20% of hepatitis B cases and 25% of hepatitis C cases were non-Libyans. Males were more affected (65%) than females (35%).

Entities:  

Mesh:

Year:  2007        PMID: 17546910

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  4 in total

Review 1.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 2.  Hepatitis C virus infection in the Middle East and North Africa "MENA" region: injecting drug users (IDUs) is an under-investigated population.

Authors:  S Ramia; N M Melhem; K Kreidieh
Journal:  Infection       Date:  2012-01-12       Impact factor: 3.553

3.  Frequency of hepatitis B, C, and HIV viruses among blood donors in Libya.

Authors:  Abdulatif Khmmaj; Elmukthar Habas; Massoud Azabi; Amna Rayani
Journal:  Libyan J Med       Date:  2010-12-14       Impact factor: 1.657

Review 4.  The epidemiology of hepatitis C virus in the Maghreb region: systematic review and meta-analyses.

Authors:  Fatima A Fadlalla; Yousra A Mohamoud; Ghina R Mumtaz; Laith J Abu-Raddad
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.